Tuesday 18th November 2024
Three innovative Irish healthcare start-ups have advanced to the next round of the prestigious EIT Health Catapult 2024-25 pitching competition.
EIT Health Ireland-UK, a co-location centre of EIT Health and part of the EU's European Institute of Innovation and Technology (EIT), has announced that Galenband, Tympany Medical, and ArrayPatch have all been selected for the semi-finals.
Galenband has developed a wearable device that provides 90-day continuous ECG monitoring for reliable, non-invasive diagnosis for intermittent heart rhythm issues.
Tympany Medical’s Solascope technology is the world’s first variable angle and self-cleaning imaging tool, creating a more sustainable and advanced approach to surgical visualisation.
ArrayPatch, a BioTech spin-out, leverages its patented microneedle technology, DerMap, to create therapeutics that are more effective and user-friendly, beginning with solutions for nail fungal infections.
The companies are three of 30 semi-finalists in this year's EIT Health Catapult, each of which has passed a rigorous pre-selection process and will receive tailored mentoring from seasoned investors, industry leaders and entrepreneurs to optimise their business plans and presentation skills.
“This year's semi-finalists represent some of the best innovation in health tech in the market today.
"The catapult program is aimed at helping these companies to scale and it's important to see these innovations make it into our healthcare systems. I'm excited for the final pitching competition in April," said Shona D'Arcy, entrepreneurship leader at EIT Health Ireland-UK.
Now in its ninth year, the EIT Health Catapult has become a launchpad for top European life sciences and healthcare start-ups.
The competition provides a unique opportunity for growth and visibility, pairing innovative start-ups with expert mentorship and investors to support their development and future funding needs.
EIT Health Catapult has supported over 330 companies over the years, many of which have achieved multi-million-euro funding rounds post-competition.
The top nine start-ups, including three from life sciences and six from healthtech will be announced in April 2025 at a networking event in Cambridge bringing together industry players, investors and the thirty semi-finalists.
The final will take place later in the year.
Irish Start-Ups
Three Irish start-ups have been selected for the EIT Health Catapult
The finalists will compete for a €30,000 cash prize in each category, along with industry in-kind prizes valued at over €800,000 from major supporters, including Amazon Web Services (AWS), eg technology, Lusíadas Saúde, and AstraZeneca.
The Alex Casta Audience Award will also return this year, offering the winner a unique opportunity to have their logo displayed on the Nasdaq Tower in New York City’s Times Square.
Source: siliconrepublic.com